Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12,107Revenue (TTM) $M4,995Net Margin (%)-26.3Altman Z-Score1.2
Enterprise Value $M15,024EPS (TTM) $-9.2Operating Margin %-0.9Piotroski F-Score7
P/E(ttm)--Beneish M-Score-2.9Pre-tax Margin (%)-30.0Higher ROA y-yY
Price/Book2.010-y EBITDA Growth Rate %--Quick Ratio1.2Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow20.1y-y EBITDA Growth Rate %--ROA % (ttm)-9.5Higher Current Ratio y-yY
Dividend Yield %0.7PEG--ROE % (ttm)-20.0Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M141ROIC % (ttm)-1.1Gross Margin Increase y-yN

Gurus Latest Trades with PRGO

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

PRGO is held by these investors:

PRGO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Janish Ronald CraigEVP, Global Op. & Supply Chain 2017-09-12Sell261$88.71-3.1view
Needham JeffreyEVP, President CHC Americas 2017-09-12Sell3,595$89.49-3.94view
Kochan SharonEVP, GM International 2017-09-07Sell318$81.365.65view
Kochan SharonEVP, GM International 2017-08-31Sell1,500$79.038.77view
Farrington ThomasEVP and CIO 2017-08-30Sell616$76.911.78view
Farrington ThomasEVP and CIO 2017-08-18Sell865$78.49.64view
Brown Judy LEVP, Business Ops & CFO 2016-11-25Sell2,097$89.44-3.89view
Parker Geoffrey M.Director 2016-11-21Buy2,500$88.75-3.14view
KINGMA TODD WExecutive VP, General Counsel 2016-11-21Sell750$88.68-3.07view
Brown Judy LEVP, Business Ops & CFO 2016-10-24Sell2,092$90.42-4.93view

Quarterly/Annual Reports about PRGO:

News about PRGO:

Articles On GuruFocus.com
Perrigo Company to Present at the Stifel 2017 Healthcare Conference Nov 10 2017 
3 Stocks Moving in Early Trading Nov 09 2017 
Perrigo Company plc Announces Quarterly Dividend Nov 02 2017 
Perrigo Announces Tentative FDA Approval for a First-to-File Generic Version of Picato® Gel 0.05% Nov 02 2017 
Perrigo To Release Third Quarter 2017 Financial Results On November 9, 2017 Oct 26 2017 
Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton® Gel Oct 26 2017 
Perrigo Announces Tentative FDA Approval For A First-To-File Generic Version Of Picato® Gel .015% Oct 24 2017 
Perrigo Announces First-To-Market Launch Of The OTC Store Brand Equivalent Of Nexium® 24HR Capsules Sep 27 2017 
Perrigo Announces FDA Final Approval For Its AB Rated Generic Version Of Exalgo® 32mg Extended Rele Sep 21 2017 
Perrigo Announces Tentative FDA Approval For The Generic Version Of Acanya® Gel Sep 18 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat